oxymatrine has been researched along with dinoprostone in 4 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 41 | 0 | 27 | 29,105 | 1,346 | 6,357 |
| 412 | 16 | 270 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | oxymatrine (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Hao, YJ; Li, YX; Ma, L; Sun, T; Wang, HB; Wang, J; Wang, SJ; Wang, YS; Yu, JQ; Zhao, P; Zhou, R | 1 |
| Cao, Z; Chen, L; Liu, Y; Peng, T | 1 |
| Cui, HL; Fu, Y; Li, CZ; Li, YY; Wu, HQ | 1 |
| Deng, N; Li, Y; Lin, H; Luo, R; Xie, L | 1 |
4 other study(ies) available for oxymatrine and dinoprostone
| Article | Year |
|---|---|
Anti-inflammation Effects of Oxysophoridine on Cerebral Ischemia-Reperfusion Injury in Mice.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Brain; Brain Ischemia; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation Mediators; Intercellular Adhesion Molecule-1; Male; Mice, Inbred ICR; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Reperfusion Injury; Signal Transduction; Time Factors; Transcription Factor RelA | 2015 |
Oxysophoridine rescues spinal cord injury via anti‑inflammatory, anti‑oxidative stress and anti‑apoptosis effects.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blood-Brain Barrier; Dinoprostone; Disease Models, Animal; Female; Gene Expression; Genes, bcl-2; Inflammation Mediators; NF-kappa B; Oxidative Stress; Rats; Spinal Cord Injuries | 2018 |
Gastroprotective and anti-ulcer effects of oxymatrine against several gastric ulcer models in rats: Possible roles of antioxidant, antiinflammatory, and prosurvival mechanisms.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antioxidants; Apoptosis; Catalase; Cell Line; Dinoprostone; Ethanol; Gastric Mucosa; Humans; Indomethacin; Inflammation; Interleukins; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Quinolizines; Rats; Rats, Sprague-Dawley; Signal Transduction; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
Oxymatrine alleviates periodontitis in rats by inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression1.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Dental Plaque Index; Dinoprostone; Female; Gingiva; Interleukin-1beta; Male; Matrix Metalloproteinases; Periodontitis; Quinolizines; Random Allocation; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Tinidazole; Tissue Inhibitor of Metalloproteinases; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |